| Name | Regional Home Care |
|---|---|
| Organization Name | Regional Home Care Inc. |
| Location | 53 Broad St, Auburn, Maine 04210 |
| Type | DME Supplier - Oxygen Equipment & Supplies |
| Phone | (207) 795-1006 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Because many countries allow the sale of energy drinks to young people, identifying ways to minimize potential harm from energy drinks is critical. A new study published in the Journal of Nutrition Education and Behavior provided unique insights into intervention strategies suggested by young people themselves to reduce consumption.
Sanofi and its subsidiary Genzyme announced today new results from the CARE-MS I trial, the first of two randomized, Phase III clinical trials comparing the investigational drug alemtuzumab to Rebif (high dose subcutaneous interferon beta-1a) in patients with relapsing-remitting multiple sclerosis.
New research in Cell Metabolism identifies a key player in the body's ability to respond to insulin action in the brain by ratcheting down the export of blood sugar from the liver.
Between 15 and 20 percent of black people carry a genetic mutation that puts them at risk for certain chronic kidney disease, but only about half of them develop the illness – a variance that long has puzzled researchers.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite the U.S. Food and Drug Administration's (FDA) recent request for postmarketing surveillance of Amgen's Prolia, the drug's expected launch this year in the United States and Europe for the treatment of osteoporosis will drive Prolia to garner blockbuster sales in 2018..
› Verified 1 days ago
| NPI Number | 1134655210 |
| Organization Name | REGIONAL HOME CARE INC |
| Type | DME Supplier - Oxygen Equipment & Supplies |
| Address | 53 Broad St, Auburn, ME 04210 |
| Phone Number | 978-840-0113 |
News Archive
Because many countries allow the sale of energy drinks to young people, identifying ways to minimize potential harm from energy drinks is critical. A new study published in the Journal of Nutrition Education and Behavior provided unique insights into intervention strategies suggested by young people themselves to reduce consumption.
Sanofi and its subsidiary Genzyme announced today new results from the CARE-MS I trial, the first of two randomized, Phase III clinical trials comparing the investigational drug alemtuzumab to Rebif (high dose subcutaneous interferon beta-1a) in patients with relapsing-remitting multiple sclerosis.
New research in Cell Metabolism identifies a key player in the body's ability to respond to insulin action in the brain by ratcheting down the export of blood sugar from the liver.
Between 15 and 20 percent of black people carry a genetic mutation that puts them at risk for certain chronic kidney disease, but only about half of them develop the illness – a variance that long has puzzled researchers.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite the U.S. Food and Drug Administration's (FDA) recent request for postmarketing surveillance of Amgen's Prolia, the drug's expected launch this year in the United States and Europe for the treatment of osteoporosis will drive Prolia to garner blockbuster sales in 2018..
› Verified 1 days ago
News Archive
Because many countries allow the sale of energy drinks to young people, identifying ways to minimize potential harm from energy drinks is critical. A new study published in the Journal of Nutrition Education and Behavior provided unique insights into intervention strategies suggested by young people themselves to reduce consumption.
Sanofi and its subsidiary Genzyme announced today new results from the CARE-MS I trial, the first of two randomized, Phase III clinical trials comparing the investigational drug alemtuzumab to Rebif (high dose subcutaneous interferon beta-1a) in patients with relapsing-remitting multiple sclerosis.
New research in Cell Metabolism identifies a key player in the body's ability to respond to insulin action in the brain by ratcheting down the export of blood sugar from the liver.
Between 15 and 20 percent of black people carry a genetic mutation that puts them at risk for certain chronic kidney disease, but only about half of them develop the illness – a variance that long has puzzled researchers.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite the U.S. Food and Drug Administration's (FDA) recent request for postmarketing surveillance of Amgen's Prolia, the drug's expected launch this year in the United States and Europe for the treatment of osteoporosis will drive Prolia to garner blockbuster sales in 2018..
› Verified 1 days ago
Cvs Pharmacy #02382 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 8 Union St, Auburn, Maine 04210 Phone: (207) 784-8101 | |
Walgreens #19397 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 61 Union St, Auburn, Maine 04210 Phone: (207) 753-0506 | |
Hannaford Food & Drug #8347 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 95 Spring St, Auburn, Maine 04210 Phone: (207) 783-0661 | |
Osco Pharmacy #2550 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 600 Center St, Auburn, Maine 04210 Phone: (207) 783-8951 | |
Bedard Medical Type: Long Term Care Pharmacy Location: 359 Minot Ave, Auburn, Maine 04210 Phone: (207) 333-3270 |